1. Rossi, Matteo, Altea-Manzano, Patricia, Demicco, Margherita, Rheenen, Jacco van, Fendt, Sarah-Maria. 2022. PHGDH heterogeneity potentiates cancer cell dissemination and metastasis. In Nature, 605, 747-753. doi:10.1038/s41586-022-04758-2. https://pubmed.ncbi.nlm.nih.gov/35585241/
2. Shen, Liliang, Zhang, Junfeng, Zheng, Zongtai, Zhang, Wentao, Yao, Xudong. 2022. PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer. In International journal of biological sciences, 18, 5459-5474. doi:10.7150/ijbs.74546. https://pubmed.ncbi.nlm.nih.gov/36147463/
3. Wei, Lai, Lee, Derek, Law, Cheuk-Ting, Wong, Carmen Chak-Lui, Wong, Chun-Ming. 2019. Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC. In Nature communications, 10, 4681. doi:10.1038/s41467-019-12606-7. https://pubmed.ncbi.nlm.nih.gov/31615983/
4. Vandekeere, Saar, Dubois, Charlotte, Kalucka, Joanna, Dewerchin, Mieke, Carmeliet, Peter. 2018. Serine Synthesis via PHGDH Is Essential for Heme Production in Endothelial Cells. In Cell metabolism, 28, 573-587.e13. doi:10.1016/j.cmet.2018.06.009. https://pubmed.ncbi.nlm.nih.gov/30017355/
5. Ma, Chunmin, Zheng, Ke, Jiang, Kun, Zhao, Yuzheng, Jiang, Yuhui. 2021. The alternative activity of nuclear PHGDH contributes to tumour growth under nutrient stress. In Nature metabolism, 3, 1357-1371. doi:10.1038/s42255-021-00456-x. https://pubmed.ncbi.nlm.nih.gov/34663976/
6. Fu, Junyi, Chen, Liqing, Su, Tangfeng, Xu, Sanqing, Liu, Yan. 2022. Mild phenotypes of phosphoglycerate dehydrogenase deficiency by a novel mutation of PHGDH gene: Case report and literature review. In International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 83, 44-52. doi:10.1002/jdn.10236. https://pubmed.ncbi.nlm.nih.gov/36308023/
7. Ngo, Bryan, Kim, Eugenie, Osorio-Vasquez, Victoria, Cantley, Lewis C, Pacold, Michael E. 2020. Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition. In Cancer discovery, 10, 1352-1373. doi:10.1158/2159-8290.CD-19-1228. https://pubmed.ncbi.nlm.nih.gov/32571778/
8. Luo, Li, Wu, Xingyun, Fan, Jiawu, Jiang, Jingwen, Wang, Kui. 2024. FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma. In Nature communications, 15, 4790. doi:10.1038/s41467-024-49087-2. https://pubmed.ncbi.nlm.nih.gov/38839752/
9. Shi, Tiezhu, Yuan, Zhihao, He, Yanying, Shao, Jialiang, Wang, Xiang. 2023. Competition between p53 and YY1 determines PHGDH expression and malignancy in bladder cancer. In Cellular oncology (Dordrecht, Netherlands), 46, 1457-1472. doi:10.1007/s13402-023-00823-8. https://pubmed.ncbi.nlm.nih.gov/37326803/